Click here to close
Hello! We notice that you are using Internet Explorer, which is not supported by Xenbase and may cause the site to display incorrectly.
We suggest using a current version of Chrome,
FireFox, or Safari.
Br J Pharmacol
2007 Jan 01;1502:235-47. doi: 10.1038/sj.bjp.0706954.
Show Gene links
Show Anatomy links
Niflumic acid inhibits chloride conductance of rat skeletal muscle by directly inhibiting the CLC-1 channel and by increasing intracellular calcium.
Liantonio A
,
Giannuzzi V
,
Picollo A
,
Babini E
,
Pusch M
,
Conte Camerino D
.
???displayArticle.abstract???
Given the crucial role of the skeletal muscle chloride conductance (gCl), supported by the voltage-gated chloride channel CLC-1, in controlling muscle excitability, the availability of ligands modulating CLC-1 are of potential medical as well as toxicological importance. Here, we focused our attention on niflumic acid (NFA), a molecule belonging to the fenamates group of non-steroidal anti-inflammatory drugs (NSAID). Rat muscle Cl(-) conductance (gCl) and heterologously expressed CLC-1 currents were evaluated by means of current-clamp (using two-microelectrodes) and patch-clamp techniques, respectively. Fura-2 fluorescence was used to determine intracellular calcium concentration, [Ca(2+)](i), in native muscle fibres. NFA inhibited native gCl with an IC(50) of 42 muM and blocked CLC-1 by interacting with an intracellular binding site. Additionally, NFA increased basal [Ca(2+)](i) in myofibres by promoting a mitochondrial calcium efflux that was not dependent on cyclooxygenase or CLC-1. A structure-activity study revealed that the molecular conditions that mediate the two effects are different. Pretreatment with the Ca-dependent protein kinase C (PKC) inhibitor chelerythrine partially inhibited the NFA effect. Therefore, in addition to direct channel block, NFA also inhibits gCl indirectly by promoting PKC activation. These cellular effects of NFA on skeletal muscle demonstrate that it is possible to modify CLC-1 and consequently gCl directly by interacting with channel proteins and indirectly by interfering with the calcium-dependent regulation of the channel. The effect of NFA on mitochondrial calcium stores suggests that NSAIDs, widely used drugs, could have potentially dangerous side-effects.
Aromataris,
Modulation of the gating of CIC-1 by S-(-) 2-(4-chlorophenoxy) propionic acid.
1999, Pubmed
Aromataris,
Modulation of the gating of CIC-1 by S-(-) 2-(4-chlorophenoxy) propionic acid.
1999,
Pubmed
Astill,
Characteristics of skeletal muscle chloride channel C1C-1 and point mutant R304E expressed in Sf-9 insect cells.
1996,
Pubmed
Conte Camerino,
Taurine and skeletal muscle disorders.
2004,
Pubmed
Conte-Camerino,
Enantiomers of clofibric acid analogs have opposite actions on rat skeletal muscle chloride channels.
1988,
Pubmed
Crompton,
The mitochondrial permeability transition pore.
1999,
Pubmed
Cruickshank,
The Cl(-) channel blocker niflumic acid releases Ca(2+) from an intracellular store in rat pulmonary artery smooth muscle cells.
2003,
Pubmed
De Luca,
Opposite effects of enantiomers of clofibric acid derivative on rat skeletal muscle chloride conductance: antagonism studies and theoretical modeling of two different receptor site interactions.
1992,
Pubmed
De Luca,
Enhanced dystrophic progression in mdx mice by exercise and beneficial effects of taurine and insulin-like growth factor-1.
2003,
Pubmed
De Luca,
Phosphorylation and IGF-1-mediated dephosphorylation pathways control the activity and the pharmacological properties of skeletal muscle chloride channels.
1998,
Pubmed
De Luca,
Aging and chloride channel regulation in rat fast-twitch muscle fibres.
1994,
Pubmed
Estévez,
Conservation of chloride channel structure revealed by an inhibitor binding site in ClC-1.
2003,
Pubmed
,
Xenbase
Fraysse,
The alteration of calcium homeostasis in adult dystrophic mdx muscle fibers is worsened by a chronic exercise in vivo.
2004,
Pubmed
Fraysse,
Decrease in resting calcium and calcium entry associated with slow-to-fast transition in unloaded rat soleus muscle.
2003,
Pubmed
Fraysse,
Fiber type-related changes in rat skeletal muscle calcium homeostasis during aging and restoration by growth hormone.
2006,
Pubmed
Gögelein,
Flufenamic acid, mefenamic acid and niflumic acid inhibit single nonselective cation channels in the rat exocrine pancreas.
1990,
Pubmed
Grynkiewicz,
A new generation of Ca2+ indicators with greatly improved fluorescence properties.
1985,
Pubmed
Hartzell,
Calcium-activated chloride channels.
2005,
Pubmed
Jordani,
Flufenamic acid as an inducer of mitochondrial permeability transition.
2000,
Pubmed
Kalgutkar,
Biochemically based design of cyclooxygenase-2 (COX-2) inhibitors: facile conversion of nonsteroidal antiinflammatory drugs to potent and highly selective COX-2 inhibitors.
2000,
Pubmed
Koch,
The skeletal muscle chloride channel in dominant and recessive human myotonia.
1992,
Pubmed
Large,
Characteristics and physiological role of the Ca(2+)-activated Cl- conductance in smooth muscle.
1996,
Pubmed
Lee,
Mechanism of action of the non-steroidal anti-inflammatory drug flufenamate on [Ca2+]i and Ca(2+)-activated currents in neurons.
1996,
Pubmed
Lee,
Inhibition of hKv2.1, a major human neuronal voltage-gated K+ channel, by meclofenamic acid.
1999,
Pubmed
Liantonio,
Structural requisites of 2-(p-chlorophenoxy)propionic acid analogues for activity on native rat skeletal muscle chloride conductance and on heterologously expressed CLC-1.
2003,
Pubmed
,
Xenbase
Liantonio,
Activation and inhibition of kidney CLC-K chloride channels by fenamates.
2006,
Pubmed
,
Xenbase
Mankodi,
Expanded CUG repeats trigger aberrant splicing of ClC-1 chloride channel pre-mRNA and hyperexcitability of skeletal muscle in myotonic dystrophy.
2002,
Pubmed
McCarty,
Voltage-dependent block of the cystic fibrosis transmembrane conductance regulator Cl- channel by two closely related arylaminobenzoates.
1993,
Pubmed
,
Xenbase
Ottolia,
Potentiation of large conductance KCa channels by niflumic, flufenamic, and mefenamic acids.
1994,
Pubmed
Papponen,
Regulated sarcolemmal localization of the muscle-specific ClC-1 chloride channel.
2005,
Pubmed
Pedersen,
Increased excitability of acidified skeletal muscle: role of chloride conductance.
2005,
Pubmed
Pedersen,
Intracellular acidosis enhances the excitability of working muscle.
2004,
Pubmed
Peretz,
Meclofenamic acid and diclofenac, novel templates of KCNQ2/Q3 potassium channel openers, depress cortical neuron activity and exhibit anticonvulsant properties.
2005,
Pubmed
Pierno,
Potential risk of myopathy by HMG-CoA reductase inhibitors: a comparison of pravastatin and simvastatin effects on membrane electrical properties of rat skeletal muscle fibers.
1995,
Pubmed
Pierno,
Change of chloride ion channel conductance is an early event of slow-to-fast fibre type transition during unloading-induced muscle disuse.
2002,
Pubmed
Pierno,
Chronic administration of taurine to aged rats improves the electrical and contractile properties of skeletal muscle fibers.
1998,
Pubmed
Pigoso,
Influence of nonsteroidal anti-inflammatory drugs on calcium efflux in isolated rat renal cortex mitochondria and aspects of the mechanisms involved.
1998,
Pubmed
Poronnik,
Intracellular Ca2+ release by flufenamic acid and other blockers of the non-selective cation channel.
1992,
Pubmed
Prisk,
Muscle injuries and repair: the role of prostaglandins and inflammation.
2003,
Pubmed
Pusch,
Mechanisms of block of muscle type CLC chloride channels (Review).
2002,
Pubmed
Pusch,
Pharmacological characterization of chloride channels belonging to the ClC family by the use of chiral clofibric acid derivatives.
2000,
Pubmed
,
Xenbase
Qu,
Functional geometry of the permeation pathway of Ca2+-activated Cl-channels inferred from analysis of voltage-dependent block.
2001,
Pubmed
,
Xenbase
Rosenbohm,
Regulation of the human skeletal muscle chloride channel hClC-1 by protein kinase C.
1999,
Pubmed
Tomisato,
Membrane permeabilization by non-steroidal anti-inflammatory drugs.
2004,
Pubmed
Tricarico,
Modulation of rat skeletal muscle chloride channels by activators and inhibitors of protein kinase C.
1991,
Pubmed
Türck,
A review of the clinical pharmacokinetics of meloxicam.
1996,
Pubmed
Uyemura,
Diclofenac sodium and mefenamic acid: potent inducers of the membrane permeability transition in renal cortex mitochondria.
1997,
Pubmed
Vane,
Mechanism of action of nonsteroidal anti-inflammatory drugs.
1998,
Pubmed
Wangemann,
Cl(-)-channel blockers in the thick ascending limb of the loop of Henle. Structure activity relationship.
1986,
Pubmed
White,
Niflumic and flufenamic acids are potent reversible blockers of Ca2(+)-activated Cl- channels in Xenopus oocytes.
1990,
Pubmed
,
Xenbase
